Performance on the Wisconsin card-sorting test and serum levels of glial cell line-derived neurotrophic factor in patients with major depressive disorder

Asia-Pacific Psychiatry

Volumn 6, Issue 3, 2014, Pages 302-307

  Zhang, Xiaobin ^a   Ru, Bu ^a   Sha, Weiwei ^a   Xin, Wang ^a   Zhou, Honghui ^a   Zhang, Yumei ^a  

^a CLINICAL MEDICAL COLLEGE OF YANGZHOU UNIVERSITY   (China)

Author keywords

Glial cell line derived neurotrophic factor (GDNF); Major depressive disorder (MDD); Wisconsin card sorting test (WCST)

Indexed keywords

GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXECUTIVE FUNCTION; FEMALE; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR BLOOD LEVEL; HAMILTON DEPRESSION RATING SCALE; HUMAN; MAJOR DEPRESSION; MALE; ONSET AGE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TASK PERFORMANCE; WISCONSIN CARD SORTING TEST; ADOLESCENT; AGED; BLOOD; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PATHOPHYSIOLOGY; PHYSIOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; DEPRESSIVE DISORDER, MAJOR; EXECUTIVE FUNCTION; FEMALE; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; YOUNG ADULT;

EID: 84929942887     PISSN: 17585864     EISSN: 17585872     Source Type: Journal    
DOI: 10.1111/appy.12120     Document Type: Article

References (40)

1. Abas M.A., Sahakian B.J., Levy R. (1990) Neuropsychological deficits and CT scan changes in elderly depressives. Psychol Med. 20, 507-520.
2. Airaksinen M.S., Saarma M. (2002) The GDNF family: signaling, biological functions and therapeutic value. Nat Rev Neurosci. 3, 383-394.
3. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders, 4th edn. American Psychiatric Press, Washington, DC.
4. Barbosa I.G., Huguet R.B., Sousa L.P., etal. (2011) Circulating levels of GDNF in bipolar disorder. Neurosci Lett. 502, 103-106.
5. Borkowska A., Drozdz W., Jurkowski P., Rybakowski J.K. (2009) The Wisconsin card sorting test and the N-back test in mild cognitive impairment and elderly depression. World J Biol Psychiatry. 10, 870-876.
6. Bowley M.P., Drervets W.C., Ongur D., Price J.L. (2002) Low glial numbers in the amygdala in major depressive disorder. Biol Psychiatry. 52, 404-412.
7. Castaneda A.E., Tuulio-Henriksson A., Marttunen M., Suvisaari J., Lonnqvist J. (2008) A review on cognitive impairments in depressive and anxiety disorder with focus on young patients. J Affect Disord. 109, 1-27.
8. Chamberlain S.R., Sahakian B.J. (2006) The neuropsychology of mood disorders. Curr Psychiatry Rep. 8, 458-463.
9. Cotter D., Mackay D., Chana G., Beasley C., Landau S., Everall I.P. (2002) Reduced neuronal size and glial cell density in area 9 of the dorsolateral prefrontal cortex in subjects with major depressive disorder. Cereb Cortex. 12, 386-394.
10. Den Hartog H.M., Derix M.M., Van Bemmel A.L., Kremer B., Jolles J. (2003) Cognitive functioning in young and middle-aged unmedicated out-patients with major depression: testing the effort and cognitive speed hypothesis. Psychol Med. 33, 1443-1451.
11. Diniz B.S., Teixeira A.L., Miranda A.S., Talib L.L., Gattaz W.F., Forlenza O.V. (2012) Circulating glial-derived neurotrophic factor is reduced in late-life depression. J Psychiatr Res. 46, 135-139.
12. Ducray A., Krebs S.H., Schaller B., Seiler R.W., Meyer M., Widmer H.R. (2006) GDNF family ligands display distinct action profiles on cultured GABAergic and serotonergic neurons of rat ventral mesencephalon. Brain Res. 1069, 104-112.
13. First M.B., Spitzer R.L., Gibbon M., Williams J.B. (1998) Structured Clinical Interview for DSM-IV (SCID-I). Biomedics Research Department, New York.
14. Frodl T., Schaub A., Banac S., etal. (2006) Reduced hippocampal volume correlates with executive dysfunctioning in major depression. J Psychiatry Neurosci. 31, 316-323.
15. Gerlai R., McNamara A., Choi-Lundberg D.L., etal. (2001) Impaired water maze learning performance without altered dopaminergic function in mice heterozygous for the GDNF mutation. Eur J Neurosci. 14, 1153-1163.
16. Gratacòs E., Pérez-Navarro E., Tolosa E., Arenas E., Alberch J. (2001) Neuroprotection of striatal neurons against kainate excitotoxicity by neurotrophins and GDNF family members. J Neurochem. 78, 1287-1296.
17. Hamilton M. (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry. 23, 56-62.
18. Heaton R.K., Chelune G.J., Talley J.L., Kay G.G., Curtis G. (1993) Wisconsin Card Sorting Test Manual. Psychological Assessment Resources, Odessa, FL.
19. Huang E.J., Reichardt L.F. (2001) Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci. 24, 677-736.
20. Kastin A.J., Akerstrom V., Pan W. (2003) Glial cell line-derived neurotrophic factor does not enter normal mouse brain. Neurosci Lett. 340, 239-241.
21. Liu Q., Zhu H.Y., Li B., Wang Y.Q., Yu J., Wu G.C. (2012) Chronic clomipramine treatment restores hippocampal expression of glial cell line-derived neurotrophic factor in a rat model of depression. J Affect Disord. 141, 367-372.
22. Malykhin N.V., Carter R., Seres P., Coupland N.J. (2010) Structural changes in the hippocampus in major depressive disorder: contributions of disease and treatment. J Psychiatry Neurosci. 35, 337-343.
23. Massman P.J., Delis D.C., Butters N., Dupont R.M., Gillin J.C. (1992) The subcortical dysfunction hypothesis of memory deficits in depression: neuropsychological validation in a subgroup of patients. J Clin Exp Neuropsychol. 14, 687-706.
24. Michel T.M., Frangou S., Camara S., etal. (2008) Altered glia cell line-derived neurotrophic factor (GDNF) concentrations in the brain of patients with depressive disorder: a comparative post-mortem study. Eur Psychiatry. 23, 413-420.
25. Otsuki K., Uchida S., Watanuki T., etal. (2008) Altered expression of neurotrophic factors in patients with major depression. J Psychiatr Res. 42, 1145-1153.
26. Ottowitz W.E., Dougherty D.D., Savage C.R. (2002) The neural network for abnormalities of attention and executive function in major depressive disorder: implications for application of the medical disease model to psychiatric disorders. Harv Rev Psychiatry. 10, 86-99.
27. Pascual A., Hidalgo-Figueroa M., Piruat J.I., Pintado C.O., Gómez-Díaz R., López-Barneo J. (2008) Absolute requirement of GDNF for adult catecholaminergic neuron survival. Nat Neurosci. 11, 755-761.
28. Pertusa M., García-Matas S., Mammeri H., etal. (2008) Expression of GDNF transgene in astrocytes improves cognitive deficits in aged rats. Neurobiol Aging. 29, 1366-1379.
29. Porter R.J., Bourke C., Gallagher P. (2007) Neuropsychological impairment in major depression: its nature, origin and clinical significance. Aust N Z J Psychiatry. 41, 115-128.
30. Rajkowska G. (2000) Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells. Biol Psychiatry. 48, 766-777.
31. Reyes J.H., O'Shea K.S., Wys N.L., etal. (2008) Glutamatergic neuronal differentiation of mouse embryonic stem cells after transient expression of neurogenin 1 and treatment with BDNF and GDNF: in vitro and in vivo studies. J Neurosci. 28, 12622-12631.
32. Rosa A.R., Frey B.N., Andreazza A.C., etal. (2006) Increased serum glial cell line-derived neurotrophic factor immunocontent during manic and depressive episodes in individuals with bipolar disorder. Neurosci Lett. 407, 146-150.
33. Rybakowski J.K., Borkowska A., Skibinska M., etal. (2006) Prefrontal cognition in schizophrenia and bipolar illness in relation to Val66Met polymorphism of the brain-derived neurotrophic factor gene. Psychiatry Clin Neurosci. 60, 70-76.
34. Salvadore G., Nugent A.C., Lemaitre H., etal. (2011) Prefrontal cortical abnormalities in currently depressed versus currently remitted patients with major depressive disorder. Neuroimage. 54, 2643-2651.
35. Sierksma A.S., van den Hove D.L., Steinbusch H.W., Prickaerts J. (2010) Major depression, cognitive dysfunction and Alzheimer's disease: is there a link? Eur J Pharmacol. 626, 72-82.
36. Takebayashi M., Hisaoka K., Nishida A., etal. (2006) Decreased levels of whole blood glial cell line-derived neurotrophic factor (GDNF) in remitted patients with mood disorders. Int J Neuropsychopharmacol. 9, 607-612.
37. Uchida S., Hara K., Kobayashi A., etal. (2011) Epigenetic status of Gdnf in the ventral striatum determines susceptibility and adaptation to daily stressful events. Neuron. 69, 359-372.
38. Wang X., Hou Z., Yuan Y., etal. (2011) Association study between plasma GDNF and cognitive function in late-onset depression. J Affect Disord. 132, 418-421.
39. Zhang X., Zhang Z., Xie C., Zhou H., Zhang Y., Sha W. (2008) Effect of treatment on serum glia cell line-derived neurotrophic factor in depressed patients. Prog Neuropsychopharmacol Biol Psychiatry. 32, 886-890.
40. Zhang X., Zhang Z., Sha W., etal. (2009) Electroconvulsive therapy increases glial cell-line derived neurotrophic factor (GDNF) serum levels in patients with drug-resistant depression. Psychiatry Res. 170, 273-275.